Salix Pharmaceuticals, Ltd (NASDAQ:SLXP) is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract.

Salix Pharmaceuticals, Ltd (NASDAQ:SLXP) achieved its new 52 week high price of $49.87 where it was opened at $49.46 UP 0.20 points or +0.41% by closing at $49.56. SLXP transacted shares during the day were over 593,767 shares however it has an average volume of 814,003 shares.

MSHL, Marshall Edwards Inc.

** MSHL reported that the U.S. Patent and Trademark Office has issued a new patent, U.S. Patent No. 8,080,675, covering a number of the Company's isoflavone-based compounds, including lead oncology-drug candidates ME-143 and ME-344, and their pharmaceutical compositions. The patent is estimated to provide protection until March 2027.

VPF, Valpey Fisher Corp.

** CTS Corporation and VPF reported that they have entered into a definitive merger agreement providing for the cash acquisition of VPF by CTS. Upon closing of the transaction, VPF will operate as an indirect wholly-owned subsidiary of CTS.